To evaluate the potential effects of LAP on hepatic function and homeostasis, we assessed whether LAP-administered mice are protected from or become more sensitive to chemically induced liver injury, fibrosis and HCC formation. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.